Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Cannabinoids in pharmaceutical development
The development of
cannabinoids in the pharmaceutical industry has exploded over the past few
year
